Nanocarriers enhance immune responses and tumor control in triple negative breast cancer, suggesting new therapy avenues.
L-arginine (L-Arg) is a key immunometabolite and nitric oxide (●NO) precursor with therapeutic potential in cancer and immunotherapy. However, its clinical application is hindered by poor bioavailability and uncontrolled dosing....
No takes yet. Share an insight, caveat, or question.
Alsharabasy et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Biomaterials Science